These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21040653)

  • 1. [In vitro assessment of vancomycin released from bone grafts].
    Melicherčík P; Jahoda D; Barták V; Klapková E; Nyč O; Pokorný D
    Acta Chir Orthop Traumatol Cech; 2010 Oct; 77(5):411-5. PubMed ID: 21040653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection methods for drug-resistant bacteria in routine examination--VISA].
    Kinoshita S; Nakamachi Y
    Rinsho Byori; 2000 Jan; Suppl 111():69-74. PubMed ID: 10804795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure.
    Whitener CJ; Park SY; Browne FA; Parent LJ; Julian K; Bozdogan B; Appelbaum PC; Chaitram J; Weigel LM; Jernigan J; McDougal LK; Tenover FC; Fridkin SK
    Clin Infect Dis; 2004 Apr; 38(8):1049-55. PubMed ID: 15095205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancellous bone as an antibiotic carrier.
    Witsø E; Persen L; Løseth K; Benum P; Bergh K
    Acta Orthop Scand; 2000 Feb; 71(1):80-4. PubMed ID: 10743999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Aug; 46(33):765-6. PubMed ID: 9272582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.
    Lubenko IY; Strukova EV; Smirnova MV; Vostrov SN; Portnoy YA; Zinner SH; Firsov AA
    J Antimicrob Chemother; 2008 Nov; 62(5):1065-9. PubMed ID: 18635520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release of vancomycin from a new biodegradable glue to prevent methicillin-resistant Staphylococcus aureus graft infection.
    Morishima M; Marui A; Yanagi S; Nomura T; Nakajima N; Hyon SH; Ikeda T; Sakata R
    Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):52-5. PubMed ID: 20360210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus.
    Tsuji BT; Rybak MJ; Lau KL; Sakoulas G
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1089-91. PubMed ID: 17158941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia.
    Khosrovaneh A; Riederer K; Saeed S; Tabriz MS; Shah AR; Hanna MM; Sharma M; Johnson LB; Fakih MG; Khatib R
    Clin Infect Dis; 2004 May; 38(9):1328-30. PubMed ID: 15127350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-resistant Staphylococcus aureus--New York, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(15):322-3. PubMed ID: 15103297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methicillin-resistant Staphylococcus aureus bacteremia. Predictor factors for an isolate with a vancomycin minimal inhibitory concentration > or =2 mg/l].
    Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
    Rev Esp Quimioter; 2008 Jun; 21(2):93-8. PubMed ID: 18509768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of vancomycin in the management of resistant staphylococcal infections.
    Kollef MH
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
    Appleman MD; Citron DM
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of daptomycin against a worldwide collection of methicillin-resistant Staphylococcus aureus.
    Brumfitt W; Hamilton-Miller JM
    Drugs Exp Clin Res; 1992; 18(9):367-9. PubMed ID: 1338590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory and bactericidal activity and selection capacity of mutants resistant and tolerant to vancomycin in Staphylococcus aureus strains].
    Villar HE; Tuchscherr L; Arena M; Longo L; Laurino G; Hoffman M
    Enferm Infecc Microbiol Clin; 1999 Nov; 17(9):454-7. PubMed ID: 10614079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.